Pfizer’s Vyndaqel and Vyndamax (Tafamidis) Treatments for TTR Amyloidosis – Webinar

Dr. Adam Castano, Sr. Medical Director for ATTR Cardiac Amyloidosis at Pfizer, presents an update on Vyndaqel/Vyndamax (Tafamidis), Pfizer’s TTR stabilizer treatment, at ASG’s 12/05/2020 ATTR webinar.

Stay Up To Date:

Receive the latest news and developments in treatment and care

Featured Resources

FAQs

1 The Core Members of an Amyloidosis Care Team ?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

2 What Treatment Options are Available for Amyloidosis?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

3 How is Amyloidosis Diagnosed?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

4 What Specialists Are Involved in the Treatment of Amyloidosis?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

Patient Care Center

Pfizer’s Vyndaqel and Vyndamax (Tafamidis) Treatments for TTR Amyloidosis – Webinar

Stay Up To Date:

Featured Resources

Caregiver Support : Taking care of yourself

Caregiver Support : Taking care of yourself

FAQs

Patient Affair Directory

Video Library